An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples